# Innovassynth Technologies (India) share price today (Innovassynth Technologies (India) Ltd, BSE: 533315)

> Innovassynth Technologies (India) share price today: ₹151.85 at the BSE close on 3 November 2026. Innovassynth Technologies (India) (BSE: 533315) is worth ₹1,411 crore and trades at a P/E of 45.5. > Innovassynth Technologies (India) Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. 533315 · Speciality Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹151.85
- P/E: 45.5×, too little history to compare yet
- Revenue (Jun 2026): ₹56.0 Cr (+356.3% on a year ago)
- Profit (Jun 2026): ₹6.7 Cr
- Operating margin: 26.7% (+153.4 points on a year ago)
- ROCE: −16%, FY26

The main question: domestic institutions moved −2.8 percentage points over 8 quarters while the business went the other way. ## What is the Innovassynth Technologies (India) share price today? Innovassynth Technologies (India) Ltd's share price was ₹151.85 at the close on 3 November 2026. It has been rising for 22 weeks. That is 52.3% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 22 weeks in a row. Since its first close in our records, on 17 April 2026, it has traded between ₹64 and ₹170, and at that close it sat 83% of the way up from that low. Over the last 6 months the share price moved +113% while the NIFTY 500 moved −5%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Innovassynth Technologies (India) this quarter? 4 points on a year earlier, indian funds and insurers (DIIs) cut their stake for 3 quarters in a row and highest quarterly revenue in 16 quarters. 1. Operating margin up 153.4 points on a year earlier 26.7% in the June 2026 quarter, from -126.6%. 2. Indian funds and insurers (DIIs) cut their stake for 3 quarters in a row From 1.5% to 1.1% of the company by the September 2026 quarter. 3. Highest quarterly revenue in 16 quarters Revenue of ₹56 crore in the June 2026 quarter is the highest of the last 16 quarters. ## What are Innovassynth Technologies (India)'s latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Innovassynth Technologies (India) reported revenue of ₹56.0 crore, up 356.3% from ₹12.3 crore a year earlier, and a profit of ₹6.74 crore, against a loss of ₹18.7 crore a year earlier. ### Innovassynth Technologies (India) results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹56.0 crore | ₹12.3 crore | +356.3% |
| Profit | ₹6.74 crore | loss of ₹18.7 crore | n/a |
| Earnings per share | ₹0.73 | ₹−5.43 | n/a |
| Operating margin | 26.7% | −126.7% | +153.4 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Innovassynth Technologies (India) share price history? Innovassynth Technologies (India) closed at ₹151.85 on 3 November 2026. Its highest weekly close since April 2026 was ₹170.00 on 9 October 2026. ### Innovassynth Technologies (India) share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹157.50 | −3.6% |
| 1 month ago · 1 Oct 2026 | ₹157.35 | −3.5% |
| 6 months ago · 30 Apr 2026 | ₹71.12 | +113.5% |
| Earliest weekly close in our records · 17 Apr 2026 | ₹71.27 | +113.1% |
| Highest weekly close since April 2026 · 9 Oct 2026 | ₹170.00 | −10.7% |
| Lowest weekly close since April 2026 · 8 May 2026 | ₹64.41 | +135.8% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (35 weekly closes from 17 April 2026 to 3 November 2026.)

## What is the latest news on Innovassynth Technologies (India)? 3 Nov 2026: Innovassynth Technologies (India) closed at ₹151.85, down 3.6% on the week and down 3.5% on the month. Results for April to June 2026: Revenue up 356.3% on a year earlier. ## What dividend does Innovassynth Technologies (India) pay? No. Innovassynth Technologies (India) Ltd paid out 0% of its profit as dividends in each of its last 12 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate (as of 3 November 2026). ## Which stock lists is Innovassynth Technologies (India) on? Innovassynth Technologies (India) is on one of our India lists: Momentum stocks. [Momentum stocks Market cap cr: 1438.742170199304](https://www.sectoralpha.in/momentum-stocks-india)

## Is Innovassynth Technologies (India) profitable? Innovassynth Technologies (India) Ltd earned ₹6.7 Cr of net profit in the Jun 2026 quarter. The full FY26 year was a loss of ₹29.0 Cr. That is 12.0% of the quarter's revenue. The same quarter a year earlier lost ₹18.7 Cr. 9 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was −₹29.0 Cr (−245.0% on the year before). ## How much revenue does Innovassynth Technologies (India) make, and is it growing? Innovassynth Technologies (India) Ltd reported ₹56.0 Cr of revenue in the Jun 2026 quarter, +356.3% on the same quarter a year earlier. The last full year, FY26, came in at ₹102 Cr. The last four reported quarters add to ₹146 Cr. A growth rate over several years is not shown, because there are too few years of figures to work one out properly. FY26 revenue was ₹102 Cr, +4.1% on the year before. ## How much of every ₹100 of sales does Innovassynth Technologies (India) keep? Innovassynth Technologies (India) Ltd's operating margin was 26.7% in the Jun 2026 quarter, 153.4 percentage points higher than the same quarter a year ago. Across 2 years it has been between −24.0% and 22.0%. Why the margin moved: operating margin changed +153.4 percentage points on the year while gross margin changed +6.1 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Innovassynth Technologies (India)'s profit turning into cash? Innovassynth Technologies (India) Ltd's cash-flow history is too short to judge how much of its profit turns into cash. In FY26 its operations used ₹39.0 Cr of cash, against −₹29.0 Cr of profit. After ₹12.0 Cr of spending on assets, free cash was −₹51.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the bigger use of cash is spending on new assets, at 12.2× depreciation over three years. The next section checks what that spending is building. ## Where does Innovassynth Technologies (India)'s cash go? Innovassynth Technologies (India) Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 266 days in FY26, up from 117 days in FY25. It spent ₹146 Cr on assets over the last 3 years. Customers take 112 days to pay, and stock sits for 530 days on average. At FY26 sales of ₹102 Cr, each day of that cycle ties up about ₹0.3 Cr, so roughly ₹74.0 Cr is tied up in the business at any time. FY26: customers took 112 days to pay and stock sat for 530 days, about 17.4 months of sales sitting as stock, for a full cycle of 266 days, longer than FY25's 117. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 530 days. Customers pay about 112 days after that. Suppliers are paid at 376 days. Together that makes the 266-day cycle. Spending on assets: ₹146 Cr over the last 3 years, against ₹12.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹4.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Innovassynth Technologies (India)'s P/E ratio, and how does it compare with its own history? Innovassynth Technologies (India) Ltd's P/E is 45.5×, with too little history to compare. Its usual P/E (the middle reading) is 27.6×, over 6 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Innovassynth Technologies (India) business getting better or worse? Innovassynth Technologies (India) Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 4 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Innovassynth Technologies (India) earn on its capital? Innovassynth Technologies (India) Ltd earned a ROCE of −16% in FY26. Its return on capital used (ROIC) is 5.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −28.4% net margin and 0.37× asset turnover (sales divided by assets). Why the return is what it is (FY26): a −28.4% net margin × 0.37× asset turnover × 2.96× leverage (assets divided by equity) ≈ −31.1% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 6.7% − 12.0% = −5.3 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Innovassynth Technologies (India) have too much debt? Innovassynth Technologies (India) Ltd had ₹113 Cr of borrowings against ₹94.0 Cr of equity in FY26, so its debt is 1.20× its equity. Its operating profit is −3 times its interest bill. Over 5 years borrowings went from ₹2.0 Cr to ₹113 Cr. Over the last 3 of those years it spent ₹146 Cr on assets. Part of the spending on assets is being paid for with borrowed money. ## What is the Innovassynth Technologies (India) shareholding pattern? Promoters raised their stake in Innovassynth Technologies (India) Ltd by 43.6 percentage points over 8 quarters, the biggest change among its owners. Promoters now own 75.0% of the company. Domestic institutions moved −2.8 points over the same period, to 1.1%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Why the owners changed: promoters drove it (+43.6 points), with the other side taken by domestic institutions (−2.8 points). They raised their stake step by step. ## How far is Innovassynth Technologies (India) from balance-sheet trouble? For Innovassynth Technologies (India) Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Innovassynth Technologies (India) rank in its industry? 44.0 out of 100, rank 21 of 30 in Speciality Chemicals, with 53% of the evidence available. Innovassynth Technologies (India) Ltd scores 44.0 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 21. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 18.3 + 4.7 + 8.6 + 12.4 = 44. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Innovassynth Technologies (India) compared with? Innovassynth Technologies (India) ranks 21 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 44.0 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 80.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 15.9/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 15.9 + 19.7 + 13.9 = 80.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.3/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.3 + 6.6 + 12.5 = 64.2 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.8/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.8 + 10.8 + 10.8 = 64 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.4/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.4 + 10 + 10.9 = 60.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 60.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.7/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.7 + 11.3 + 11.4 = 60.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.8/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.8 + 9.7 + 14.8 = 59.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.5/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.5 + 5.7 + 19.5 = 59 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.7/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.7 + 16.1 + 7.8 = 55.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.2 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.9 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 53.0 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative
15. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.8 out of 100 Growth Capital Valuation Relative
16. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.5 out of 100 Growth Capital Valuation Relative
17. [Chemcon Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd) CHEMCON · breaking out · Evidence leans up · 85% evidence 51.1 out of 100 Growth Capital Valuation Relative
18. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 47.9 out of 100 Growth Capital Valuation Relative
19. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
20. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.8 out of 100 Growth Capital Valuation Relative
21. Innovassynth Technologies (India) Ltd this page breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.3/35 · Revenue 100% · Profit 66.7% · Operating margin change 153.4 points · 62% evidence Capital efficiency 4.7/25 · ROCE -16.4% · Operating margin 26.7% · 95% evidence Valuation 8.6/20 · P/E 115.6× · PEG n/a · 15% evidence Relative strength 12.4/20 · Lead over its industry n/a · Lead over NIFTY 500 67.7% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 18.3 + 4.7 + 8.6 + 12.4 = 44 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 22. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
23. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 42.5 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.5 out of 100 Growth Capital Valuation Relative
26. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.4 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.2 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Innovassynth Technologies (India) in size? Innovassynth Technologies (India) is the 17th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Vishnu Chemicals, Grauer & Weil (India) and Panama Petrochem. Just below it: Paushak, Thirumalai Chemicals and Platinum Industries. ### Speciality Chemicals companies close in size

1. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) ₹3,650 crore
2. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) ₹3,640 crore
3. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) ₹2,726 crore
4. Innovassynth Technologies (India) Ltd ₹1,468 crore
5. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) ₹1,450 crore
6. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) ₹1,378 crore
7. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) ₹1,215 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [Renaissance Global Ltd](https://www.sectoralpha.in/stocks/renaissance-global-ltd) ₹1,474 crore · Lab Grown Diamonds
2. [Hypersoft Technologies Ltd](https://www.sectoralpha.in/stocks/hypersoft-technologies-ltd) ₹1,470 crore · IT - Software
3. Innovassynth Technologies (India) Ltd ₹1,468 crore
4. [Meghna Infracon Infrastructure Ltd](https://www.sectoralpha.in/stocks/meghna-infracon-infrastructure-ltd) ₹1,462 crore · Finance - Capital Markets - Brokers
5. [Summit Securities Ltd](https://www.sectoralpha.in/stocks/summit-securities-ltd) ₹1,460 crore · Finance - Capital Markets - Brokers

## What else do people ask about Innovassynth Technologies (India)? ### What is Innovassynth Technologies (India)'s share price today? Innovassynth Technologies (India) Ltd's share price is ₹151.85. The whole company is worth ₹1,411 Cr on the market. In the last 52 weeks it traded between ₹64 to ₹170; today it is 83% of the way up from the low, 52.3% above its 200-day average. The price has been rising for 22 weeks (as of 3 November 2026). ### What were Innovassynth Technologies (India)'s latest quarterly results? Innovassynth Technologies (India) Ltd reported revenue of ₹56.0 Cr and net profit of ₹6.7 Cr for the Jun 2026 quarter. Earnings per share were ₹0.73. The operating margin was 26.7%, 153.4 percentage points higher than a year earlier (as of 3 November 2026). ### What is Innovassynth Technologies (India)'s market cap? Innovassynth Technologies (India) Ltd's market capitalisation is ₹1,411 Cr at a share price of ₹151.85. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Innovassynth Technologies (India) performing? Innovassynth Technologies (India) Ltd's share price has been rising for 22 weeks. Over the past 13 weeks it has done better than the NIFTY 500, for 22 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Is Innovassynth Technologies (India) in an uptrend? Yes, the price has been rising for 22 weeks (stage 2 of 4), 52.3% above its 200-day average, and 83% of the way up its 52-week range. A share price tends to move through four phases: moving sideways, rising, stalling and falling (as of 3 November 2026). ### Will Innovassynth Technologies (India)'s share price go up? This page does not forecast Innovassynth Technologies (India) Ltd's share price. What it shows instead: the share price is ₹151.85, and it has been rising for 22 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Who owns Innovassynth Technologies (India)? Promoters own 75.0% of Innovassynth Technologies (India) Ltd, foreign institutions 1.1%, domestic institutions 1.1% and the public 22.7% (latest quarter). The biggest change over the last two years: Promoters raised their stake by 43.6 percentage points over 8 quarters (as of 3 November 2026). ### Where is Innovassynth Technologies (India) in its business cycle? Innovassynth Technologies (India) Ltd's FY26 operating margin was −24.0%, against a 2-year range of −24.0% to 22.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 26.7%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Innovassynth Technologies (India) story? The main question: domestic institutions moved −2.8 percentage points over 8 quarters while the business went the other way. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Innovassynth Technologies (India) a stock worth studying right now? What the numbers show: Innovassynth Technologies (India) Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the owners’ moves turn back in line with the business. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- Momentum stocks: https://www.sectoralpha.in/momentum-stocks-india

This is research, not advice. We’re not SEBI-registered.